Literature DB >> 21793922

Survival and durability of mitral valve repair surgery for degenerative mitral valve disease.

Paolo Nardi1, Antonio Pellegrino, Antonio Scafuri, Carlo Olevano, Carlo Bassano, Jacob Zeitani, Luigi Chiariello.   

Abstract

AIM OF THE STUDY: To evaluate the results after standardized techniques of mitral valve repair (MVr) for treatment of degenerative mitral regurgitation (MR) and to analyze risk factors for late outcomes.
METHODS: Two hundred and sixty-one patients (mean age 63 ± 12 years) underwent MVr between January 1999 and January 2010 for degenerative MR. In the last five years, all repair techniques were performed routinely using annuloplasty prosthetic ring, with or without quadrangular or triangular resection of posterior leaflet and/or edge-to-edge technique as always indicated by intraoperative transesophageal echocardiography. Mean follow-up (99% complete) was 54 ± 38 (range, 6 to 137) months.
RESULTS: Operative mortality was 0.8% (2/261), 10-year actuarial survival 89%± 3%. At 10 years of follow-up freedom from cardiac death was 94%± 2.6%, from reoperation 95%± 2.4%, from thromboembolism 96%± 2.1%, and from endocarditis 100%. Independent predictor of late all-causes mortality was advanced age at operation (71 ± 10 years vs. 62 ± 12 years, p = 0.0068). Late progression to moderate or severe MR was observed in 12/256 patients (4.7%). Independent predictor of late progression to moderate or severe MR was annuloplasty without the use of prosthetic ring (p = 0.04). Reoperation was required in six patients (2.3%). Follow-up echocardiography showed improvement of MR, left ventricular end-diastolic and end-systolic diameters, left atrial diameter, and systolic pulmonary artery pressure (p < 0.0001 for all comparisons with preoperative values).
CONCLUSIONS: MVr is a low-risk, durable surgical procedure. Standardized techniques, with the routine use of prosthetic ring, improve late results.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21793922     DOI: 10.1111/j.1540-8191.2011.01275.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  8 in total

1.  Lifting posterior mitral annuloplasty for enhancing leaflet coaptation in mitral valve repair: midterm outcomes.

Authors:  Meong Gun Song; Je Kyoun Shin; Hyun Keun Chee; Jun Seok Kim; Hyun Suk Yang; Jong Bum Choi
Journal:  Ann Cardiothorac Surg       Date:  2015-05

Review 2.  Classic resectional technique for mitral valve repair: triangular resection via right anterior thoracotomy.

Authors:  Elizabeth Pocock; Peter I Tsai; Sandeep Markan; Scott A Weldon; Todd K Rosengart
Journal:  Ann Cardiothorac Surg       Date:  2015-09

Review 3.  Pediatric Myocarditis: What Have We Learnt So Far?

Authors:  Elettra Pomiato; Marco Alfonso Perrone; Rosalinda Palmieri; Maria Giulia Gagliardi
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-03

4.  Chordae replacement versus leaflet resection in minimally invasive mitral valve repair.

Authors:  Tomas Holubec; Simon H Sündermann; Stephan Jacobs; Volkmar Falk
Journal:  Ann Cardiothorac Surg       Date:  2013-11

5.  Chordal replacement versus quadrangular resection in degenerative posterior mitral leaflet repair.

Authors:  Kangmu Ma; Anqing Chen; Zhe Wang; Jun Liu; Qiang Zhao
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

6.  Predictors of 30-day outcomes following mitral valve repair.

Authors:  Adam M Reisman; A Taylor Thomas; Percy Boateng; I Michael Leitman
Journal:  Ann Med Surg (Lond)       Date:  2019-09-10

7.  Outcomes of Mitral Valve Repair: Quadrangular Resection versus Chordal Replacement.

Authors:  Kwon-Jae Park; Jong Soo Woo; Jung Hoon Yi; Jong Yoon Park
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-04-09

8.  Echocardiographic Follow-up of Robotic Mitral Valve Repair for Mitral Regurgitation due to Degenerative Disease.

Authors:  Yao Wang; Chang-Qing Gao; Yan-Song Shen; Gang Wang
Journal:  Chin Med J (Engl)       Date:  2016-09-20       Impact factor: 2.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.